micro 4 Flashcards

1
Q

corynebacterium diphtheria charcteristics

A
catalase positive 
club shaped rods 
gram positive 
palisade like 
immotile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

corynebacterium diphtheria reservior

A

only humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

talk about diphtheria toxin

A

encoded by tox gene introduced into bacteria by lysogenic bacteriophage which is an exotoxin made of 2 subunits
A : has a catalytic region to inhibit elongation factor EF-2
B that has receptor binding and translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

two main clinical presentations of diphtheria

A

respiratory and cutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

respiratory diphtheria

A

exaudative pharyngitis low grade fever and sore throat
pharyngeal exaudate is firmly adherent pseudomembrane in oropharynx after a week it gets dislodged and expectorated
bull neck
systemic spread of toxin causes myocarditis and neurotoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cutaneous diphtheria

A

papule that develops into chronic non healing ulcer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

lab diagnosis of diphtheria

A

culture in tellurite contain media (HOYLE and TINSDALE )

toxigenicity test by ELEK or PCR for tox gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

most important treatment step for corynebacterium diphtheria

A

administration of antitoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

antibiotic for corynebacterium diphtheria

A

penicillin and erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bacillus anthracis charc and how is it acquired

A

gram positive , spore former

acquired by occupational exposure to herbivorous animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

main virulence factors of Bacillus anthracis

A

toxin component ;
PA , LF and EF
polypeptide capsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

role of each component of Bacillus anthracis toxin

A

PA ; cell binding and endocytosis
EF: increase camp
LF ; stimulate IL-1 and TNF alpha augment IR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ANTHRAX FORMS and charac

A

cutaneous (hide porters ) : commonest and least severe, 12 days after injury a pupule forms that then forms to blister then central necrosis and hemorrhage (BLACK ISCHAR) before falling
Gastrointes. : mucosal ulceration and mesentric LAP
inhalation ( wood sorter) : symp 2 months after spore entry (mediastinal infection and mediastinal LAP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is Bacillus anthracis diffrentiated from rest of Bacillus species

A

immotile
non hemolytic on sheep blood agar
medusa head

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

anthrax treated by

A

ciprofloxacin and doxycycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

bordetella pertussis charac

A

strict aerobic , gram - coccobacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

does bordetella pertussis have any reservoir other than humans

A

no

18
Q

pathogenicity of bordetella pertussis

A

attachment by protein adhesin ( pertactin , hemagglutinin) and fimbrie
tissue damage : dermonecrotic toxin (ischemia)
tracheal cytotoxin
systemic toxicity by pertussis toxin :
no control over adenylate cyclase cause increase in cAMP , hyperglycemia , lymphocytosis

19
Q

bordetella pertussis incubation period

A

7-10 days

20
Q

stages of bordetella pertussis clinical illness

A
  • catarrhal (1-2 wks) : common cold , bacterial shedding is highest
  • paroxysmal (2-4 wks) : whooping cough paroxsyms and lymphocystosis
  • convalescent (3 wks) ; decreased paroxsymal intensity but complications ( pneumonia , seizures , encephalopathy)
21
Q

how to detect bordetella pertussis on culture

A

on Bordet Gingou agar or regan lowe agar

22
Q

what to do to decrease transmission and shorten disease course of bordetella pertussis

A

antibiotics within given 3 weeks of cough onset

23
Q

first line of bordetella pertussis

A

macrolide ( azithromycin)

24
Q

vaccine of bordetella pertussis

A

acellular pertussis toxoid vaccine (aP)

25
Q

when is ap toxoid vaccine given in jordanian national program

A

2,3,4 mths

booster at 18

26
Q

post exposure prophylaxis of bordetella pertussis

A

azithromycin

27
Q

actinomyces spp charac

A

gram +
branching filament
anaerobic strictly

28
Q

main specie of actinomyces

A

a. israelii

29
Q

what does a. israelii do clinically

A

actinomycosis (chronic inflam. with formation of granuloma that is supparative )
also there are abscesses that are connected by sinus tract

30
Q

the pus that is secreted by a. israelii has what granules

A

sulfur granules

yellowish masses bound by calcium phosphate

31
Q

actinomycoses forms

A

cervicofacial : poor oral hygiene
thoracic : lung abcess
abdominal: appendix and ileocecal
pelvic: with IUCD lead to tuboovarian abcess)

32
Q

actinomycosis diagnosed by

A

microscopy of sulfur granules

33
Q

DOC of actinomycosis

A

penicillin

34
Q

nocardia like what spp

A

actinomyces but it is aerobic and have a beaded appearance

35
Q

members of nocardia

A

N. asteroides and N. brasilienses

36
Q

clinical feautures of nocardia

A

bronchopulmonary disease
cutaneous : mycetoma and lymphocutaneous
brain disease

37
Q

diagnosis of nocardia culture

A

culture needs 5-10% CO2 and BCYE

38
Q

mass spectrometry and molecular methods of nocardia

A

mass spectrometry : MALDI-TOF MS

molecular : 16rRNA gene sequence

39
Q

DOC for nocardia

A

co-trimaxazole

40
Q

treatment of nocardia is prolonged

A

true ( 12 mths or more)